RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
China Medical System Holdings Stock

China Medical System Holdings EBIT 2024

China Medical System Holdings EBIT

1.98 B CNY

Ticker

867.HK

ISIN

KYG211081248

WKN

A1JLYP

In 2024, China Medical System Holdings's EBIT was 1.98 B CNY, a -27.2% increase from the 2.72 B CNY EBIT recorded in the previous year.

The China Medical System Holdings EBIT history

YEAREBIT (undefined CNY)
2027e4
2026e3.14
2025e2.35
2024e1.98
20232.72
20223.64
20213.22
20202.81
20192.4
20182.01
20171.9
20161.55
20151.07
20141.12
20130.7
20120.58
20110.4
20100.24
20090.19
20080.13
20070.09
20060.04
20050.06
20040.05

China Medical System Holdings Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into China Medical System Holdings, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by China Medical System Holdings from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects China Medical System Holdings’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of China Medical System Holdings. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into China Medical System Holdings’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing China Medical System Holdings’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on China Medical System Holdings’s growth potential.

China Medical System Holdings Revenue, EBIT and net profit per share

DateChina Medical System Holdings RevenueChina Medical System Holdings EBITChina Medical System Holdings Net Income
2027e12.73 B undefined4 B undefined3.29 B undefined
2026e10.27 B undefined3.14 B undefined2.64 B undefined
2025e8.97 B undefined2.35 B undefined2.04 B undefined
2024e7.9 B undefined1.98 B undefined1.79 B undefined
20238.01 B undefined2.72 B undefined2.4 B undefined
20229.15 B undefined3.64 B undefined3.26 B undefined
20218.34 B undefined3.22 B undefined3.02 B undefined
20206.95 B undefined2.81 B undefined2.53 B undefined
20196.07 B undefined2.4 B undefined1.96 B undefined
20185.43 B undefined2.01 B undefined1.85 B undefined
20175.35 B undefined1.9 B undefined1.67 B undefined
20164.9 B undefined1.55 B undefined1.38 B undefined
20153.55 B undefined1.07 B undefined995.94 M undefined
20142.95 B undefined1.12 B undefined1.05 B undefined
20132.25 B undefined701.6 M undefined636.2 M undefined
20121.78 B undefined580.8 M undefined536.5 M undefined
20111.36 B undefined402.6 M undefined402.4 M undefined
2010894.6 M undefined237.8 M undefined207 M undefined
2009658.8 M undefined187.4 M undefined141.3 M undefined
2008504.5 M undefined128.4 M undefined103.9 M undefined
2007393.5 M undefined92.4 M undefined66 M undefined
2006300 M undefined44 M undefined32 M undefined
2005271.1 M undefined55.1 M undefined40 M undefined
2004227.3 M undefined48.2 M undefined29.6 M undefined

China Medical System Holdings stock margins

The China Medical System Holdings margin analysis displays the gross margin, EBIT margin, as well as the profit margin of China Medical System Holdings. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for China Medical System Holdings.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the China Medical System Holdings's sales revenue. A higher gross margin percentage indicates that the China Medical System Holdings retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the China Medical System Holdings's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the China Medical System Holdings's total revenue generated. When comparing the revenue margin year over year, investors can gauge the China Medical System Holdings's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the China Medical System Holdings. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the China Medical System Holdings's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

China Medical System Holdings Margin History

China Medical System Holdings Gross marginChina Medical System Holdings Profit marginChina Medical System Holdings EBIT marginChina Medical System Holdings Profit margin
2027e76.24 %31.4 %25.87 %
2026e76.24 %30.56 %25.73 %
2025e76.24 %26.2 %22.72 %
2024e76.24 %25.03 %22.64 %
202376.24 %33.89 %29.96 %
202276.89 %39.76 %35.62 %
202174.93 %38.59 %36.19 %
202073.92 %40.43 %36.43 %
201974.85 %39.58 %32.28 %
201872.09 %37.06 %34.05 %
201765.03 %35.46 %31.31 %
201659.42 %31.53 %28.08 %
201557.58 %30.11 %28.03 %
201456.18 %37.99 %35.51 %
201354.53 %31.2 %28.29 %
201258.82 %32.66 %30.17 %
201156.62 %29.61 %29.6 %
201059.09 %26.58 %23.14 %
200963.1 %28.45 %21.45 %
200861.67 %25.45 %20.59 %
200764.93 %23.48 %16.77 %
200668.9 %14.67 %10.67 %
200574.14 %20.32 %14.75 %
200476.46 %21.21 %13.02 %

China Medical System Holdings Aktienanalyse

What does China Medical System Holdings do?

China Medical System Holdings Ltd is a leading pharmaceutical conglomerate specializing in the development, manufacturing, and marketing of drugs in China. The company was founded in 1995 and is headquartered in Shenzhen. The history of China Medical System began as a small company based in Hong Kong, specializing in the import of drugs from Europe and the United States. In 2004, the company expanded its business into the Chinese market and began marketing products in China. Through a consistent expansion strategy and targeted investments, the company was able to become a major player in the Chinese pharmaceutical market in a short period of time. Today, China Medical System is one of the largest pharmaceutical companies in China with a wide portfolio of products and services. China Medical System's business model is focused on marketing drugs in China. The company works closely with its international partners and licenses their products for the Chinese market. In addition, China Medical System has its own research and development departments that work on developing new drugs for the Chinese market. The various divisions of China Medical System encompass a wide range of products and services. The company operates in the areas of preparative chemistry, clinical development, pharmaceutical distribution, and marketing. The company also offers services such as clinical trials and other consulting services. Some of China Medical System's most well-known products include the anti-tumor drug Endostar, used for the treatment of lung cancer, and the hepatitis B drug Fufangdanshen. The company has also entered into a number of collaboration agreements with international pharmaceutical companies such as Sanofi and Eli Lilly to market their products in China. Overall, the company has built a strong position in the Chinese market throughout its history and makes significant contributions to the research, development, and marketing of drugs in China. China Medical System Holdings ist eines der beliebtesten Unternehmen auf Eulerpool.com.

EBIT Details

Analyzing China Medical System Holdings's EBIT

China Medical System Holdings's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of China Medical System Holdings's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

China Medical System Holdings's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in China Medical System Holdings’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about China Medical System Holdings stock

How much did China Medical System Holdings achieve in EBIT for the current year?

In the current year, China Medical System Holdings has achieved an EBIT of 1.98 B CNY.

What is EBIT?

EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company China Medical System Holdings.

How has the EBIT of China Medical System Holdings developed in recent years?

The EBIT of China Medical System Holdings has increased by -27.204% decreased compared to the previous year.

What does EBIT mean for investors?

EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.

Why is EBIT an important indicator for investors?

Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.

Why do EBIT values fluctuate?

EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.

What role does tax burden play in EBIT?

Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.

How is EBIT presented in the balance sheet of the company China Medical System Holdings?

The EBIT of China Medical System Holdings is listed in the income statement.

Can EBIT be used as a single indicator for evaluating a company?

EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.

Why is EBIT not equal to net profit?

The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.

How much dividend does China Medical System Holdings pay?

Over the past 12 months, China Medical System Holdings paid a dividend of 0.62 CNY . This corresponds to a dividend yield of about 8.53 %. For the coming 12 months, China Medical System Holdings is expected to pay a dividend of 0.69 CNY.

What is the dividend yield of China Medical System Holdings?

The current dividend yield of China Medical System Holdings is 8.53 %.

When does China Medical System Holdings pay dividends?

China Medical System Holdings pays a quarterly dividend. This is distributed in the months of June, June, September, September.

How secure is the dividend of China Medical System Holdings?

China Medical System Holdings paid dividends every year for the past 17 years.

What is the dividend of China Medical System Holdings?

For the upcoming 12 months, dividends amounting to 0.69 CNY are expected. This corresponds to a dividend yield of 9.58 %.

In which sector is China Medical System Holdings located?

China Medical System Holdings is assigned to the 'Health' sector.

Wann musste ich die Aktien von China Medical System Holdings kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of China Medical System Holdings from 9/9/2024 amounting to 0.02 CNY, you needed to have the stock in your portfolio before the ex-date on 8/30/2024.

When did China Medical System Holdings pay the last dividend?

The last dividend was paid out on 9/9/2024.

What was the dividend of China Medical System Holdings in the year 2023?

In the year 2023, China Medical System Holdings distributed 0.616 CNY as dividends.

In which currency does China Medical System Holdings pay out the dividend?

The dividends of China Medical System Holdings are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von China Medical System Holdings

Our stock analysis for China Medical System Holdings Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of China Medical System Holdings Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.